StockNews.com Initiates Coverage on NovaBay Pharmaceuticals (NYSE:NBY)
Research analysts at StockNews.com began coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Get Free Report) in a report issued on Sunday. The firm set a “hold” rating on the stock. Separately, Ascendiant Capital Markets reduced their price target on shares of NovaBay Pharmaceuticals from $8.00 to $0.85 and set a “buy” rating for the […]
Research analysts at StockNews.com began coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Get Free Report) in a report issued on Sunday. The firm set a “hold” rating on the stock. Separately, Ascendiant Capital Markets reduced their price target on shares of NovaBay Pharmaceuticals from $8.00 to $0.85 and set a “buy” rating for the […]
